[C@@H](NC)C(C)(C)C1C=CC=CC=1)C(=O)N(C)[C@H](/C=C(\C)/C(O)=O)C(C)C](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10688_1621562304.gif?v=1742886559)
Riociguat - CAS# 625115-55-1 carbazone Smiles: CC(C)(C)[C@H](NC(=O)[C@@H](NC)C(C)(C)C1C=CC=CC=1)C(=O)N(C)[C@H](/C=C(\C)/C(O)=O)C(C)C
Pay in 4 interest-free payments of $27.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Live Spec
Riociguat - CAS# 625115-55-1 carbazone Smiles: CC(C)(C)[C@H](NC(=O)[C@@H](NC)C(C)(C)C1C=CC=CC=1)C(=O)N(C)[C@H](/C=C(\C)/C(O)=O)C(C)CRiociguat, also known as BAY 63 2521, is a novel drug that is currently in clinical development by Bayer. It is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class
Store: yutopean.com · Domain: yutopean.com
